2011 Annual Meeting | Assessment of Rapidly Progressive Dementias and Related Neurologic Conditions

Date Saturday 04/09/11

Time 04:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Allen J. Aksamit, Jr., MD, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnoses and work-up of common and uncommon conditions that may present as RPDs, including Creutzfeldt-Jakob disease and its many imitators.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
04:00 PM - 04:05 PM		Introduction Allen J. Aksamit, Jr., MD, F�鶹��ýӳ��
04:00 PM - 06:00 PM		Break
04:05 PM - 04:35 PM		Creutzfeldt-Jakob Disease and Related Disorders Michael D. Geschwind, MD, PhD, F�鶹��ýӳ��
04:35 PM - 04:40 PM		Questions and Answers Michael D. Geschwind, MD, PhD, F�鶹��ýӳ��
04:40 PM - 05:10 PM		Paraneoplastic and Autoimmune Disorders Steven Vernino, MD, PhD, F�鶹��ýӳ��
05:10 PM - 05:15 PM		Questions and Answers Steven Vernino, MD, PhD, F�鶹��ýӳ��
05:15 PM - 05:45 PM		Degenerative Disorders Bradley F. Boeve, MD, F�鶹��ýӳ��
05:45 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Allen J. Aksamit, Jr., MD, F�鶹��ýӳ��	Dr. Aksamit has nothing to disclose.
Bradley F. Boeve, MD, F�鶹��ýӳ��	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Michael D. Geschwind, MD, PhD, F�鶹��ýӳ��	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Steven Vernino, MD, PhD, F�鶹��ýӳ��	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.